PDCD1 and neoplasm: In the context of anti-tumor immune response, a primary regulatory role has to be ascribed to immune checkpoint (IC) molecules (e.g., Programmed Cell Death-1 (PD-1), Programmed death ligand 1 (PD-L1), Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4), etc.).